fda on semaglutide approves obesity drug that helped people cut weight 15% FDA alerts health care providers,

The researchers also studied the financial impacts if a government health care program, such as Medicare, were to expand its coverage of weight loss drugs for medical treatments beyond diabetes or sleep apnea

doi: 10.1038/nature22350 20 PeyronCTigheDKvan den PolANde LeceaLHellerHCSutcliffeJGet al

According to the medications prescribing information, pregnant rats, rabbits, and monkeys that received semaglutide (Ozempic) experienced higher rates of pregnancy loss, birth defects, and low birth weight

All patients basal insulin was transitioned to degludec, and short-acting insulin to insulin aspart, for the purpose of standardization

The evolving roles of alternative splicing